DUBLIN--(BUSINESS WIRE)--The "Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive insights about marketed and Phase III products for Opioid-Induced Constipation. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.
Coverage of API manufacturers for Opioid-Induced Constipation marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' names along with their locations.
This report provides a comprehensive understanding of the emerging Phase III therapies for Opioid-Induced Constipation which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Key Topics Covered:
1. Report Introduction
2. Opioid-Induced Constipation: Overview
- Risk Factors
- Causes
- Symptoms
- Pathophysiology
- Prognosis
- Diagnosis
- Treatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed Therapies
- Product Description
- Route of Synthesis
- Mechanism of Action
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Adverse Reactions
- Clinical Trials
- Regulatory Milestones
- Product Development Activities
- Historical Global Sales
- Forecasted Global Sales
5. Emerging Therapies (Phase III)
- Product Description
- Research and Development
- Product Development Activities
